Table 3.
Common potential late effects, associated risk factors and health screening recommendations for pediatric CNS (central nervous system) tumsor survivors
Potential Late Effect | Risk Factor | Health Screening Recommendations ** |
---|---|---|
Altered Bone Composition
|
Chemotherapy: antimetabolite (methotrexate Corticosteroids: (dexamethasone Radiation: Brain |
History: joint pain, swelling, immobility, limited range of motion Physical: musculoskeletal exam Imaging: bone density evaluation |
Cerebrovascular Complications
|
Radiation: Brain (≥18cGy) |
History: hemiparesis, hemiplegia, weakness, aphasia Physical: neurologic exam Measurements: blood pressure Imaging: MRI Brain, MRA Referral: Neurology, Physical and Occupational therapy |
Dental Problems
|
Any chemotherapy Radiation: Brain |
History: dry mouth Physical: oral exam Referral: Dental |
Endocrine: Gonadal Dysfunction Female:
|
Chemotherapy: alkylating agents (busulfan, cyclophosphamide, ifosfamide, lomustine, procarbazine, thiotepa) and heavy metals (carboplatin, cisplatin Radiation: Spine |
History (All): pubertal onset, tempo of puberty, sexual function History (Females): menstruation, pregnancy Physical (All): tanner staging Physical (Male): testicular volume Screening Labs (Females): FSH/LH, Estradiol level Screening Labs (Males): FSH/LH, Morning Testosterone, Sperm analysis Referral (All): Reproductive endocrinology Referral (Females): Gynecology, Referral (Males): Urology |
Endocrine: Hormonal Deficiency
|
Radiation: Brain | See above |
Endocrine: Metabolic Syndrome
|
Radiation: Brain Neurosurgery: Brain (suprasellar region) |
History: polyuria, polydipsia, polyphagia Measurements: Height, Weight, BMI Labs: Na, K, glucose, Cl, CO2, fasting lipid panel, insulin, HgA1C, Referral: Endocrinology |
Endocrine: Hypothalamic Pituitary Dysfunction
|
Radiation: Brain (≥ 18cGy Radiation: Brain (≥ 30cGy) |
History: previous growth velocity, fatigue, onset of puberty, nutritional status Physical (All): tanner staging Physical (Male): testicular volume Measurements: height, weight, BMI (Note the corresponding percentile on growth chart Imaging: bone age Labs (All): CBC, Electrolytes, LFTs, FSH/LH, TSH, Free T4, Labs (Male): testosterone level Referral: Endocrinology |
Endocrine: Hypothalamic Pituitary Dysfunction
|
Radiation: Brain (≥ 30cGy) |
History: anorexia, dehydration, hypoglycemia, lethargy, unexplained HTN Labs: morning cortisol |
Endocrine: Hypothalamic Pituitary Dysfunction
|
Radiation: Brain (≥ 30cGy) |
History: fatigue, wt gain cold intol, constipation, weight gain, dry skin, brittle hair, depressed mood PE: ht, wt, hair, skin, thyroid Labs: Free T4 |
Endocrine: Hypothalamic Pituitary Dysfunction
|
Radiation: Brain (≥ 40cGy) |
History: galactorrhea or decreased libido Labs: prolactin if pt has galactorrhea, or decreased libido |
Endocrine: Obesity
|
Radiation: Brain |
History: diet and activity level Measurements: height, weight, BMI, blood pressure Referral: Nutritionist |
Endocrine: Thyroid Problems
|
Radiation: Brain/Spine |
History: fatigue, cold intolerance, constipation, weight gain, dry skin, brittle hair, depressed mood Physical: hair, skin, thyroid exam Measurements: height, weight (Note the corresponding percentile on growth chart Labs: TSH, Free T4 Referral: Endocrinology |
ENT Problems
|
Radiation: Brain |
History: rhinorrhea, nasal discharge Referral: ENT |
Eye Problems
|
Corticosteroids: (dexamethasone Radiation: Brain Chemotherapy: busulfan |
History: visual changes (decreased acuity, diplopia Physical: eye exam (visual acuity, fundoscopic exam for lens opacity Referral: Ophthalmologist |
GI: Bowel Dysfunction
|
Neurosurgery: Spinal Cord |
History: Chronic constipation, Fecal soiling Physical: Rectal exam Referral: GI |
GU: Bladder Dysfunction
|
Radiation: Spine (lumbar, sacral, cauda equina Neurosurgery: Spinal Cord |
History: urinary urgency/frequency, urinary incontinence/retention, dysuria, nocturia, abnormal urinary stream Measurements: blood pressure Labs: BUN, Creatinine, Na, K, Cl, CO,Ca, Mg, PO4; Urinalysis Referral: Urology |
GU: Urinary Tract Dysfunction
|
Chemotherapy: alkylating agents (cyclophosphamide, ifosfamide Radiation: Spine (sacral, total spine) |
History: Urinary urgency/frequency, urinary incontinence/retention, dysuria, nocturia, abnormal urinary stream Measurements: blood pressure Labs: BUN, Creatinine, Na, K, Cl, CO, Ca, Mg, PO4, Urinalysis Referral: Urology |
GU: Renal
|
Chemotherapy:, carboplatin, cisplatin, cyclophosphamide |
Measurement: blood pressure Labs: same as above Referral: Nephrology |
Hearing Problems
|
Chemotherapy: heavy metals (carboplatin, cisplatin) |
History: hearing difficulty, tinnitus, vertigo Physical: otoscopic exam Screening: audiogram Referral: Audiology; speech therapy for patients with hearing loss. |
Ototoxicity
|
Radiation Brain >30 | See above |
Musculoskeletal Alteration: Growth Problems
|
Radiation: Spine (all fields) |
Measurements: limb lengths, sitting height, height, weight Referral: Orthopedic |
Musculoskeletal Alteration: Spine Deformity
|
Radiation: Spine Neurosurgery: Spinal Cord (laminectomy, laminoplasty) |
Physical: spine exam for scoliosis and kyphosis Referral: Orthopedic |
Neurocognitive Dysfunction
|
Chemotherapy: antimetabolite (methotrexate Radiation: Brain Neurosurgery: Brain |
History: educational and/or vocational progress Physical: neurologic exam Screening: formal neuropsychological evaluation Referral: Neuropsychology |
Neurological: Clinical leukoencephalopathy
|
Chemotherapy: antimetabolite (methotrexate), cytarabine Radiation: Brain ≥24cGy Neurosurgery: Brain |
History: cognitive, motor, sensory deficits, seizures, other neurologic symptoms Physical: neurologic exam Imaging: MRI Brain, MRA Referral: Neurology |
Neurological: Impaired CSF Diversion
|
Neurosurgery: Brain |
Imaging: X-ray shunt series (skull and abdominal images Referral: Neurosurgery |
Neurological: Motor and/or sensory deficits
|
Neurosurgery: Brain |
Physical: neurologic exam Referral: Neurology, Physiatrist/rehabilitation medicine specialist, speech, physical, occupational therapies |
Neurosensory Problems: Peripheral motor and/or sensory neuropathy
|
Chemotherapy with plant alkaloids (vinblastine, vincristine)and heavy metals (carboplatin, cisplatin) |
History: areflexia, weakness, foot drop, paresthesias, dysesthesias Physical: neurologic exam Referral: Neurologist and physical therapy for symptomatic neuropathy |
Pulmonary Dysfunction
|
Chemotherapy: alkylating agents (lomustine, busulfan) |
History: Cough, SOB, DOE, wheezing, poor growth Measurements: height, weight Physical: Pulmonary exam Screening: PFTs (complete pulmonary function testing) |
Psychosocial/Behavioral
|
Any cancer experience |
History: psychosocial assessment (educational and/or vocational progress, social withdrawal Referral: Psychiatry |
Second Malignancy
|
Chemotherapy: epipodophyllotoxins (etoposide Chemotherapy: high dose alkylating agents (cyclophosphamide, ifosfamide, lomustine) |
History: fatigue, bleeding, easy bruising Physical: dermatological exam (pallor, petechiae, purpura Labs: CBC, bone marrow exam as indicated Referral: Oncology |
Second Malignancy
|
Chemotherapy: high dose alkylating agents (cyclophosphamide, ifosfamide, lomustine) |
History: hematuria, urinary urgency, urinary frequency, dysuria Labs: Urinalysis Referral: Urology |
Second Malignancy
|
Radiation: Brain/Spine |
Physical: thyroid exam Referral: Endocrinology |
Second Malignancy
|
Radiation: Brain |
History: headaches, vomiting, cognitive, motor or sensory deficits, seizures and other neurologic symptoms; skin changes (i.e. moles Physical: Neurologic exam, Ophthalmology exam, Dermatological exam Imaging: MRI Brain Referral: Oncology, Neurology, Neurosurgery, Dermatology |
Sexual Dysfunction
|
Neurosurgery: Spinal Cord |
History (Males): erectile/ejaculatory dysfunction History (Females): altered, diminished or loss of sensation, dyspareunia Referral (Males): Urology Referral (Females): Gynecology Referral (All): counseling |
Children’s Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancer version 4.0. http://www.survivorshipguidelines.org/pdf/LTFUGuidelines_40.pdf. October 2013. Accessed 12/01/14